1. Home
  2. FLNC vs BHVN Comparison

FLNC vs BHVN Comparison

Compare FLNC & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fluence Energy Inc.

FLNC

Fluence Energy Inc.

HOLD

Current Price

$19.77

Market Cap

1.7B

Sector

Miscellaneous

ML Signal

HOLD

BHVN

Biohaven Ltd.

HOLD

Current Price

$14.96

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLNC
BHVN
Founded
2018
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
FLNC
BHVN
Price
$19.77
$14.96
Analyst Decision
Hold
Buy
Analyst Count
17
14
Target Price
$15.71
$29.08
AVG Volume (30 Days)
12.6M
3.6M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
N/A
N/A
Revenue
$2,262,830,000.00
N/A
Revenue This Year
$51.23
N/A
Revenue Next Year
$21.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.06
$7.48
52 Week High
$33.51
$18.57

Technical Indicators

Market Signals
Indicator
FLNC
BHVN
Relative Strength Index (RSI) 43.61 71.10
Support Level $18.90 $14.83
Resistance Level $23.90 $15.71
Average True Range (ATR) 3.14 0.94
MACD -0.64 0.38
Stochastic Oscillator 3.51 82.08

Price Performance

Historical Comparison
FLNC
BHVN

About FLNC Fluence Energy Inc.

Fluence Energy Inc provides intelligent energy storage and optimization software for renewables and storage. Its energy storage solutions and operational services support a more resilient grid and help unlock the potential of renewable portfolios. The company's offerings include energy storage solutions, recurring operational and maintenance services, and Software-as-a-Service (SaaS) products designed to meet customer business needs, performance requirements, in-house capabilities, and risk profiles. Its service plans offer varying levels of training, maintenance, guarantees, warranties, and support for active system management. The company operates in the Americas, APAC and EMEA, with the majority of revenue coming from the Americas.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: